Biljana Brezina
Overview
Explore the profile of Biljana Brezina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
A Treat-to-Target Approach in IBD: Contemporary Real-World Perspectives from an International Survey
Sharip M, Brezina B, De La Revilla Negro J, Subramanian S, Parkes M, Raine T, et al.
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941338
: The management of inflammatory bowel disease (IBD) varies due to differences in healthcare systems, treatment costs, access to diagnostics, and diverse clinical practices between specialists. Despite the frequent advocacy...
2.
Noor N, Lee J, Bond S, Dowling F, Brezina B, Patel K, et al.
Lancet Gastroenterol Hepatol
. 2024 Feb;
9(5):415-427.
PMID: 38402895
Background: Management strategies and clinical outcomes vary substantially in patients newly diagnosed with Crohn's disease. We evaluated the use of a putative prognostic biomarker to guide therapy by assessing outcomes...
3.
Noor N, Brezina B, De La Revilla Negro J, Dowling F, Bond S, Whitehead L, et al.
Clin Med (Lond)
. 2022 Oct;
22(Suppl 4):22-23.
PMID: 36220241
No abstract available.
4.
Jayne D, Walsh M, Merkel P, Peh C, Szpirt W, Puechal X, et al.
Health Technol Assess
. 2022 Sep;
26(38):1-60.
PMID: 36155131
Background: Anti-neutrophil cytoplasm antibody-associated vasculitis is a multisystem, autoimmune disease that causes organ failure and death. Physical removal of pathogenic autoantibodies by plasma exchange is recommended for severe presentations, along...
5.
Walsh M, Merkel P, Peh C, Szpirt W, Puechal X, Fujimoto S, et al.
N Engl J Med
. 2020 Feb;
382(7):622-631.
PMID: 32053298
Background: More effective and safer treatments are needed for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Methods: We conducted a randomized trial with a 2-by-2 factorial design to evaluate the use of...
6.
Kronbichler A, Brezina B, Gauckler P, Quintana L, Jayne D
Autoimmun Rev
. 2019 Mar;
18(5):510-518.
PMID: 30844548
Refractory lupus nephritis indicates an inadequate response to lupus nephritis therapy. It implies persisting or worsening disease activity despite therapy, but the definition is complicated by the parameters of response,...
7.
Kronbichler A, Brezina B, Quintana L, Jayne D
Autoimmun Rev
. 2015 Aug;
15(1):38-49.
PMID: 26318215
Extracorporeal treatments have been used since the 1970s in the management of systemic lupus erythematosus (SLE). A randomised controlled trial comparing the efficacy of standard of care (SOC) combined with...